News
October 5, 2021

BioCrossroads president joins Regenstrief Institute Board of Directors

The president and chief executive officer of BioCrossroads, Patricia (Patty) Martin, MBA, is joining the Regenstrief Institute Board of Directors as its treasurer. She was appointed to this role because of her experience and ability to integrate science and business.

Before that, she worked at Eli Lilly and Company for 26 years, where she served as chief operating officer of Lilly Diabetes, chief diversity officer and chief alliance officer. She also had leadership roles in clinical product development, finance, business development, human resources and investor relations.

Actively involved in Indiana’s life sciences community, Martin serves as a board member of Indiana Biosciences Research Institute and Indiana Health Information Exchange. Beyond Indiana, she serves on the boards of CareSource, Inc., Flame Biosciences, Inc., and AN2 Therapeutics.

Martin was named president and CEO of BioCrossroads in 2019. Through her current position, she is helping to advance Indiana’s life sciences sector by, convening Indiana’s research institutions, global companies, philanthropic organizations, and government agencies to ignite growth and innovation, accelerate sector success, foster entrepreneurism, and enable collaboration.

A graduate of Indiana University, Martin also earned her MBA from the Harvard School of Business.

Regenstrief’s board provides strategic guidance, oversight and management for the internationally respected medical research organization in support of its mission to improve local, national and global healthcare delivery and outcomes through research and innovative advances in aging, biomedical informatics and health services.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

  • Patty Martin

Related News

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists and fellows shared work on artificial intelligence, health information exchange and public health informatics at

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight